Chinese expert consensus on the use of sulbactam to treat patients infected with Acinetobacter baumannii in the neurosurgical intensive care unit

Chinese expert consensus on the use of sulbactam to treat patients infected with Acinetobacter baumannii in the neurosurgical intensive care unit

Treatment of neurosurgical intensive care patients infected with multidrug resistant (MDR) or extensive drug resistant (XDR) Acinetobacter baumannii presents significant challenges and is associated with high mortality rates. Sulbactam has long been an effective treatment for MDR Acinetobacter bauma...

Full description

Bibliographic Details
Main Authors: Neurosurgical Branch, Chinese Medical Association, Chinese Neurosurgical Intensive Care Management Collaborative Group
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2024-06-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
neurosurgical procedures
critical care
acinetobacter baumannii
sulbactam
diagnostic and treatment guideline
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/2873

Internet

http://www.cjcnn.org/index.php/cjcnn/article/view/2873

Similar Items